During the past decade, Lungenklinik Hemer, Pneumologie und Thorakale Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Thoraxklinik-Heidelberg gGmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie" are "NSCLC, Stage III" (1 trials) and "Pleural Mesothelioma Malignant" (1 trials). Many other conditions were trialed in "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie" in a lesser frequency.

Most popular intervention types in "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie" are "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin AUC 5" (1 trials), "Cisplatin 75 mg/m2" (1 trials), "Durvalumab Injection [Imfinzi]" (1 trials), "Nivolumab Injection" (1 trials) and "Pemetrexed 500 mg/m2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lungenklinik Hemer, Pneumologie und Thorakale Onkologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lungenklinik Hemer, Pneumologie und Thorakale Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lungenklinik Hemer, Pneumologie und Thorakale Onkologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".